Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels
Video Player is loading.
Post ASCO 2021 Expert Panel Discussion on Breast Cancers: Adjuvant Olaparib for High-Risk EBC, Metastatic CDK4/6i, Talazoparib for BRCA1/2-m EBC, PBC vs. Capecitabine for TNBC
Comments 0
Login to view comments.
Click here to Login
